Need professional-grade analysis? Visit stockanalysis.com
$86.85M
N/A
20
N/A
Neovici Holding AB (publ) (IDLDX) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at SEK0.34, down 7.01% from the previous close.
Over the past year, IDLDX has traded between a low of SEK0.26 and a high of SEK0.59. The stock has lost 41.1% over this period. It is currently 41.5% below its 52-week high.
Neovici Holding AB (publ) has a market capitalization of $86.85M.
IDL Diagnostics AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden. It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cells; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever. Its vitro diagnostic biomarkers are used in breast, bladder, and prostate cancer therapies. The company was formerly known as AroCell AB (publ) and changed its name to IDL Diagnostics AB (publ) in May 2025. IDL Diagnostics AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
Side-by-side comparison against top Healthcare peers.